Long
MNLO is a BUY
This pharma has benefited from massive institutional buying as of late. From a charting perspective it looks to have broken out and successfully retested the trendline breakout. Go long from here
Note
21st May 2020 - nice retest of the broken trendline and heading higher. 12% return so farNote
26th May 2020 - a 28% return on this trade so far
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.